Aquaporin 4-specific T cells and NMO-IgG cause primary retinal damage in experimental NMO/SD.

PubWeight™: 0.90‹?›

🔗 View Article (PMID 27503347)

Published in Acta Neuropathol Commun on August 08, 2016

Authors

Bleranda Zeka1, Maria Hastermann1, Nathalie Kaufmann1, Kathrin Schanda2, Marko Pende3, Tatsuro Misu4, Paulus Rommer5, Kazuo Fujihara4, Ichiro Nakashima4, Charlotte Dahle6, Fritz Leutmezer5, Markus Reindl2, Hans Lassmann1, Monika Bradl7

Author Affiliations

1: Department of Neuroimmunology, Center for Brain Research, Medical University Vienna, Spitalgasse 4, A-1090, Vienna, Austria.
2: Clinical Department of Neurology, Innsbruck Medical University, Innsbruck, Austria.
3: Medical University Vienna, Section for Bioelectronics, Center for Brain Research, Vienna, Austria.
4: Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan.
5: Department of Neurology, Medical University Vienna, Wien, Austria.
6: Department of Clinical and Experimental Medicine, Faculty of Health Sciences, Linköping University, Linköping, Sweden.
7: Department of Neuroimmunology, Center for Brain Research, Medical University, 1090 Vienna, Austria;

Articles cited by this

A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet (2004) 13.18

IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med (2005) 10.39

A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain (2002) 6.85

Blood supply of the optic nerve head and its role in optic atrophy, glaucoma, and oedema of the optic disc. Br J Ophthalmol (1969) 5.15

Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo. Ann Neurol (2009) 3.91

Aquaporin-4 water channel protein in the rat retina and optic nerve: polarized expression in Müller cells and fibrous astrocytes. J Neurosci (1998) 2.11

M2 macrophages phagocytose rituximab-opsonized leukemic targets more efficiently than m1 cells in vitro. J Immunol (2009) 2.06

New functions of Müller cells. Glia (2013) 1.93

Retinal astrocytes are immigrants from the optic nerve. Nature (1988) 1.75

Aquaporin 4-specific T cells in neuromyelitis optica exhibit a Th17 bias and recognize Clostridium ABC transporter. Ann Neurol (2012) 1.75

The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement. Am J Pathol (1993) 1.59

Orchestrated leukocyte recruitment to immune-privileged sites: absolute barriers versus educational gates. Nat Rev Immunol (2013) 1.39

Neuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomography. Mult Scler (2015) 1.30

Blood-retinal barrier (BRB) breakdown in experimental autoimmune uveoretinitis: comparison with vascular endothelial growth factor, tumor necrosis factor alpha, and interleukin-1beta-mediated breakdown. J Neurosci Res (1997) 1.29

Pathogenic T cell responses against aquaporin 4. Acta Neuropathol (2011) 1.16

The dynamics of leukocyte infiltration in experimental autoimmune uveoretinitis. Prog Retin Eye Res (2008) 1.07

What is the Thalamus in Zebrafish? Front Neurosci (2012) 1.06

Transient axonal injury in the absence of demyelination: a correlate of clinical disease in acute experimental autoimmune encephalomyelitis. Acta Neuropathol (2006) 1.05

Highly encephalitogenic aquaporin 4-specific T cells and NMO-IgG jointly orchestrate lesion location and tissue damage in the CNS. Acta Neuropathol (2015) 1.00

Increased T-cell immunity against aquaporin-4 and proteolipid protein in neuromyelitis optica. Int Immunol (2011) 0.96

T cell-activation in neuromyelitis optica lesions plays a role in their formation. Acta Neuropathol Commun (2013) 0.96

Deletion of aquaporin-4 renders retinal glial cells more susceptible to osmotic stress. J Neurosci Res (2010) 0.94

Selective and antigen-dependent effects of myelin degeneration on central nervous system inflammation. J Neuropathol Exp Neurol (2004) 0.93

Myelin basic protein specific T-helper cells induce experimental anterior uveitis. J Neurosci Res (1996) 0.90

CRALBP is a highly prevalent autoantigen for human autoimmune uveitis. Clin Dev Immunol (2007) 0.86

Clinicopathological features in anterior visual pathway in neuromyelitis optica. Ann Neurol (2016) 0.85

T-cell responses to distinct AQP4 peptides in patients with neuromyelitis optica (NMO). Mult Scler Relat Disord (2015) 0.83

Orally induced bystander suppression in experimental autoimmune uveoretinitis occurs only in the periphery and not in the eye. Eur J Immunol (1995) 0.83

Novel rodent models for macular research. PLoS One (2010) 0.83

Localization and ontogeny of aquaporin-1 and -4 expression in iris and ciliary epithelial cells in rats. Cell Tissue Res (2006) 0.83

Induction of experimental autoimmune encephalomyelitis by CD4+ T cells specific for an astrocyte protein, S100 beta. J Neural Transm Suppl (1997) 0.82

T cell immunity to myelin basic protein induces anterior uveitis in Lewis rats. J Neuroimmunol (1994) 0.82

Anterior uveitis in murine relapsing experimental autoimmune encephalomyelitis (EAE), a mouse model of multiple sclerosis (MS). Curr Eye Res (2000) 0.80

Glio-vascular modifications caused by Aquaporin-4 deletion in the mouse retina. Exp Eye Res (2016) 0.80

Articles by these authors

Safety and efficacy of rituximab in neuromyelitis optica spectrum disorders (RIN-1 study): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol (2020) 3.93

Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease. Mult Scler (2014) 1.56

Serological assessment for celiac disease in IgA deficient adults. PLoS One (2014) 0.85

Insights into the classification of myasthenia gravis. PLoS One (2014) 0.83

Japanese POEMS syndrome with Thalidomide (J-POST) Trial: study protocol for a phase II/III multicentre, randomised, double-blind, placebo-controlled trial. BMJ Open (2015) 0.82

Clinical spectrum associated with MOG autoimmunity in adults: significance of sharing rodent MOG epitopes. J Neurol (2016) 0.79

Bilateral frontal cortex encephalitis and paraparesis in a patient with anti-MOG antibodies. J Neurol Neurosurg Psychiatry (2017) 0.78

Severely exacerbated neuromyelitis optica rat model with extensive astrocytopathy by high affinity anti-aquaporin-4 monoclonal antibody. Acta Neuropathol Commun (2015) 0.78

Experimental Neuromyelitis Optica Induces a Type I Interferon Signature in the Spinal Cord. PLoS One (2016) 0.78

Features of Human CD3+CD20+ T Cells. J Immunol (2016) 0.78

An antibody microarray analysis of serum cytokines in neurodegenerative Parkinsonian syndromes. Proteome Sci (2012) 0.76

Cerebrospinal fluid CXCL13 is a prognostic marker for aseptic meningitis. J Neuroimmunol (2014) 0.76

Safety and efficacy of thalidomide in patients with POEMS syndrome: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol (2016) 0.75

MOG-IgG serological status matters in paediatric ADEM. J Neurol Neurosurg Psychiatry (2014) 0.75

Japanese cases of neuromyelitis optica spectrum disorder associated with myasthenia gravis and a review of the literature. Clin Neurol Neurosurg (2014) 0.75

RGMa signal in Macrophages Induces Neutrophil-related Astrocytopathy in NMO. Ann Neurol (2022) 0.75